Report cover image

Global Theranostics Market Growth, Size, Trends Analysis - By Product, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jun 27, 2025
Length 259 Pages
SKU # SPER20265984

Description

Theranostics Market Introduction and Overview

According to SPER market research, ‘Global Theranostics Market Size- By Product, By Application, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Theranostics Market is predicted to reach 9.15 billion by 2034 with a CAGR of 13.85%.

Theranostics combines “therapy” and “diagnostics,” integrating tests and treatments in medicine. This approach tailors patient care by considering individual factors like disease biology and genetics. Diagnostic methods identify specific biomarkers, guiding the choice of suitable therapies, which can include targeted drugs, immunotherapies, or radiation therapies, aimed at increasing effectiveness and reducing side effects.

Restraints:Theranostics products are expensive to develop, test, and approve. Manufacturing costs are also costly since production procedures are difficult and need the use of advanced technologies. Economies of scale may be difficult to achieve because the majority of theranostic products are speciality or niche goods. Furthermore, the use of these technology results in additional costs for altering healthcare facilities. Patients bear the significant costs.

Scope of the report:
Report Metric Details Market size available for years 2021-2034 Base year considered 2024 Forecast period 2025-2034

Segments covered
By Product, By Application, By End-User

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Bayer AG, Beckman Coulter, Inc, Cardinal Health, Inc, Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd, GE HealthCare Technologies Inc, Koninklijke Philips N.V, Lantheus Holdings, Inc, Siemens Healthnieers AG, Thermo Fisher Scientific Inc.

Global Theranostics Market Segmentation:

By Product:Based on the Product, Global Theranostics Market is segmented as; Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software, Services.

By Application:Based on the Application, Global Theranostics Market is segmented as; Prostate Cancer, Bone Metastasis, Neuroendocrine Tumors, Lymphoma, Cardiovascular diseases.

By End User:Based on the End User, Global Theranostics Market is segmented as; Hospitals, Diagnostics centers, Specialty clinics, Other end-users.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

259 Pages
1. Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPERs internal database
2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTER’s Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Theranostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Theranostics Market
7.Global Theranostics Market, By Product (USD Million) 2021-2034
7.1.Diagnostic imaging
7.1.1.MRI
7.1.2.PET imaging
7.1.3.Nuclear imaging
7.1.4.CT scan
7.1.5.Molecular imaging
7.1.6.Other diagnostic imaging
7.2.Radiopharmaceuticals
7.2.1.Lutetium-177
7.2.2.Samarium-153
7.2.3.Radium-223
7.2.4.Iodine-131
7.2.5.Yttrium-90
7.2.6.Gallium-68
7.2.7.Fluorine-18
7.2.8.Other radiopharmaceuticals
7.3.IVD/Biomarker screening
7.3.1.Polymerase chain reaction (PCR)
7.3.2.Next-generation sequencing (NGS)
7.3.3.Fluorescence in-situ hybridization (FISH)
7.4.Software and services
8.Global Theranostics Market, By Application (USD Million) 2021-2034
8.1.Prostate cancer
8.2.Bone metastasis
8.3.Neuroendocrine tumors
8.4.Lymphoma
8.5.Cardiovascular diseases
8.6.Other applications
9.Global Theranostics Market, By End-User (USD Million) 2021-2034
9.1.Hospitals
9.2.Diagnostics centers
9.3.Specialty clinics
9.4.Other end-users
10.Global Theranostics Market, (USD Million) 2021-2034
10.1.Global Theranostics Market Size and Market Share
11.Global Theranostics Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia
11.1.2.China
11.1.3.India
11.1.4.Japan
11.1.5.South Korea
11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France
11.2.2.Germany
11.2.3.Italy
11.2.4.Spain
11.2.5.United Kingdom
11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia
11.3.2.United Arab Emirates
11.3.3.Qatar
11.3.4.South Africa
11.3.5.Egypt
11.3.6.Morocco
11.3.7.Nigeria
11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada
11.4.2.Mexico
11.4.3.United States
11.5.Latin America
11.5.1.Argentina
11.5.2.Brazil
11.5.3.Rest of Latin America
12.Company Profile
12.1.Bayer AG
12.1.1.Company details
12.1.2.Financial outlook
12.1.3.Product summary
12.1.4.Recent developments
12.2.Beckman Coulter, Inc
12.2.1.Company details
12.2.2.Financial outlook
12.2.3.Product summary
12.2.4.Recent developments
12.3.Cardinal Health, Inc
12.3.1.Company details
12.3.2.Financial outlook
12.3.3.Product summary
12.3.4.Recent developments
12.4.Canon Medical Systems Corporation
12.4.1.Company details
12.4.2.Financial outlook
12.4.3.Product summary
12.4.4.Recent developments
12.5.Curium
12.5.1.Company details
12.5.2.Financial outlook
12.5.3.Product summary
12.5.4.Recent developments
12.6.F. Hoffmann La Roche Ltd
12.6.1.Company details
12.6.2.Financial outlook
12.6.3.Product summary
12.6.4.Recent developments
12.7.GE HealthCare Technologies Inc
12.7.1.Company details
12.7.2.Financial outlook
12.7.3.Product summary
12.7.4.Recent developments
12.8.Koninklijke Philips N.V
12.8.1.Company details
12.8.2.Financial outlook
12.8.3.Product summary
12.8.4.Recent developments
12.9.Siemens Healthnieers AG
12.9.1.Company details
12.9.2.Financial outlook
12.9.3.Product summary
12.9.4.Recent developments
12.10.Thermo Fisher Scientific Inc
12.10.1.Company details
12.10.2.Financial outlook
12.10.3.Product summary
12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us